References
- The WHO position paper on BCG vaccine. Weekly Epidemiological Record 2004;79:27-38.
- Kim MS, Jo DS, Kyung KM, Kim SJ, Kim JS. The effect of local rifampicin instillation on the treatment of suppurative BCG lymphadenitis. Korean J Pediatr 2006;49:40-5. https://doi.org/10.3345/kjp.2006.49.1.40
- Hwang JS, Choi YY, Ma JS, Hwang TJ. A Clinical study on BCG lymphadenitis. J Korean Pediatr Soc 1997;40:614-9.
- Kim KH, Lee SJ, Lee K. PPD conversion rate and complications according to the different time of BCG vaccination. J Korean Pediatr Soc 1987;30:487-90.
- Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698-702. https://doi.org/10.1001/jama.271.9.698
- Ustvedt HJ. Local reaction in BCG vaccination. Bull World Health Organ 1950;2:441-68.
- Hsing CT. Local complications of BCG vaccination in pre-school children and new-born babies. Bull World Health Organ 1954;11:1023-9.
- Caglayan S AA, Yaprak I, Aksoz K, Kansoy S. Mangement of suppuration in regional lymph nodes secondary to BCG vaccination. Acta Paediatr Jpn 1991; 33:699-702. https://doi.org/10.1111/j.1442-200X.1991.tb02593.x
- Caglayan S YO, Kayran K, Timocin N, Kasirga E, Gun M. Is medical therapy effective for regional lymphadenitis following BCG vaccination? Am J Dis Child 1987;141:1213-4.
- WHO. Expanded Programme on immunization: Immunization policy. WHO 1986:14-5.
- The Korean Pediatric Society. General recommendations on immunizations. 6th ed. Seoul: Kwang Moon Co, 2008:43-58.
- Lotte A, Watz-Hockert O, Poisson N, Dumitrescu N, Verron M, Couvet E. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res 1984;21:107-93.
- Lotte A, Wasz-Hockert O, Poisson N, Engbaek H, Landmann H, Quast U, et al. Second IUATLD study on complications induced by intradermal BCGvaccination. Bull Int Union Tuberc Lung Dis 1988;63: 47-59.
- Kroger L, Brander E, Korppi M, Wasz-Hockert O, Backman A, Kroger H, et al. Osteitis after newborn vaccination with three different Bacillus Calmette- Guerin vaccines: twenty-nine years of experience. Pediatr Infect Dis J 1994;13:113-6. https://doi.org/10.1097/00006454-199402000-00007
- Bergdahl S, Fellander M, Robertson B. BCG osteomyelitis: experience in the Stockholm region over the years 1961-1974. J Bone Joint Surg Br 1976; 58:212-6.
- Paul EM, Ilona AM, Milstien B, John C. Issues relating to the use of BCG in immunization programmes. Department of vaccines and biologicals: World Health Organization; 1999.
- Teo SS, Smeulders N, Shingadia DV. BCG vaccineassociated suppurative lymphadenitis. Vaccine 2005;23: 2676-9. https://doi.org/10.1016/j.vaccine.2004.07.052
- Oh JT, Kim IG, Han SJ, Hwang EH. Management of BCG lymphadenitis. J Korean Assoc Pediatr Surg 1997; 3:143-7.
- Baek HS, Chang JY, Moon SJ, Oh SH. Lymphadenitis following intradermal BCG vaccination. Korean J Pediatr 2006;49:46-50. https://doi.org/10.3345/kjp.2006.49.1.46
- Turnbull FM, McIntyre PB, Achat HM, Wang H, Stapledon R, Gold M, et al. National study of adverse reactions after vaccination with bacille Calmette- Guerin. Clin Infect Dis 2002;34:447-53. https://doi.org/10.1086/338462
- Kim MJ, Jang SH, Ahn YM, Kang MK, Kim SJ. Local Rifampicin Instillation Therapy for Suppurative Bacillus Calmette-Guerin Lymphadenitis. J Korean Pediatr Soc 2002;45:454-8.
- Hengster P, Schnapka J, Fille M, Menardi G. Occurrence of suppurative lymphadenitis after a change of BCG vaccine. Arch Dis Child 1992;67:952-5. https://doi.org/10.1136/adc.67.7.952
- Smith D HG, Chan J, Edwards M, Hank J, Muller D, et al. Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigs. J Biol Stand 1979; 7:179-97. https://doi.org/10.1016/S0092-1157(79)80021-9
- Gheorghiu M CH, Lagrange P, Chambon L. Potency and suppurative adenitis in BCG vaccination. Dev Biol Stand 1978;41:79-85.
- Kim SH, Kim SY, Eun BW, Yoo WJ, Park KU, Choi EH, et al. BCG osteomyelitis caused by the BCG Tokyo strain and confirmed by molecular method. Vaccine 2008;26:4379-81. https://doi.org/10.1016/j.vaccine.2008.06.004
- Close GC, Nasiiro R. Management of BCG adenitis in infancy. J Trop Pediatr 1985;31:286. https://doi.org/10.1093/tropej/31.5.286
- Hanley SP, Gumb J, Macfarlane JT. Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination. Br Med J 1985;290:970. https://doi.org/10.1136/bmj.290.6473.970
- Murphy PM, Mayers DL, Brock NF, Wagner KF. Cure of bacille Calmette-Guerin vaccination abscesses with erythromycin. Rev Infect Dis 1989;11:335-7. https://doi.org/10.1093/clinids/11.2.335
- Ministry of Health and Welfare. Adverse events and management following BCG vaccination. Document No. 655. 1995:40-818.
- Goraya JS, Virdi VS. Treatment of Calmette-Guerin Bacillus adenitis: a meta analysis. Pediatr Infect Dis J 2001;20:632-33. https://doi.org/10.1097/00006454-200106000-00020
- The Korean National Tuberculosis Association. Expert Knowledge about BCG vaccination. Available from: http://www.knta.or.kr
- Banani SA, Alborzi A. Needle aspiration for suppurative post-BCG adenitis. Arch Dis Child 1994;71: 446-7. https://doi.org/10.1136/adc.71.5.446